SynthesisFrontiers in endocrinology2026
Incremental effects of SGLT2 inhibitors, GLP-1 receptor agonists, and pioglitazone in type 2 diabetes and MASLD across Asian study settings: a systematic review and meta-analysis.
Hanwen Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.